Plus, news about AriBio, Arcera, Molecular Partners, Valneva, MacroGenics, Sagard Healthcare Partners, Quell Therapeutics, AstraZeneca, Guardian Bio, Lucy Therapeutics, Argenica, and Gilead’s Tmunity:
Insmed’s stock jumps on PAH data: In Phase 2 results, Insmed ...
↧